Ostermann H, Tschöpe D, Greber W, Meyer-Rüsenberg H W, van de Loo J
Department of Internal Medicine, University of Münster, FRG.
Thromb Haemost. 1992 Oct 5;68(4):400-3.
The fibrinolytic system was studied in 96 patients with type I diabetes mellitus. Patients were grouped according to their degree of retinopathy; 38 patients with no evidence of retinopathy, 28 patients with background retinopathy and 30 patients with proliferative retinopathy. Thirty healthy individuals served as controls. The basal fibrinolytic activity as measured by clot lysis time and t-PA activity was increased in diabetic patients. This was associated with low levels of plasminogen activator inhibitor. Increased levels of D-dimer in diabetic patients further indicate enhanced in vivo fibrinolysis. The increase in fibrinolytic activity was highest in diabetics without retinopathy, and decreased with increasing retinopathy. Endothelial release of t-PA after venous occlusion was not different between controls and all diabetic groups. These findings suggest that in type I diabetics the fibrinolytic system is in an activated state. With worsening of retinopathy this increase in fibrinolytic activity diminishes.
对96例I型糖尿病患者的纤溶系统进行了研究。根据患者的视网膜病变程度进行分组:38例无视网膜病变证据的患者,28例有背景性视网膜病变的患者和30例有增殖性视网膜病变的患者。30名健康个体作为对照。通过凝块溶解时间和组织型纤溶酶原激活物(t-PA)活性测定的基础纤溶活性在糖尿病患者中增加。这与纤溶酶原激活物抑制剂水平降低有关。糖尿病患者中D-二聚体水平升高进一步表明体内纤溶增强。无视网膜病变的糖尿病患者纤溶活性增加最高,并随着视网膜病变加重而降低。对照组和所有糖尿病组之间静脉闭塞后内皮细胞释放t-PA没有差异。这些发现表明,I型糖尿病患者的纤溶系统处于激活状态。随着视网膜病变的加重,这种纤溶活性的增加会减弱。